- Preamble [SYSTEM]
- Fund & Investor Interest
- Street Moves
- Solebury Trout Updates
- Market Commentary
- IPO News
- Expert Interactions
- Banker Comments & Notes
- Conference Snippet
- Industry Snippets
- Social Media
- Solebury Trout Talks

IPO News: Filed S-1/A: Avidity Biosciences Launches 10mm Share IPO with $14-$16 Marketing Range
Avidity Biosciences
Nasdaq: RNA
Filing Date: 05/22/20
Launch Date: 06/08/20
Price Range: $14.00 - $16.00
Shares Offered (Pre-Shoe, mm): 10.0
Primary Shares (mm): 10.0
Secondary Shares (mm): 0.0
Amount Offered (@ Midpoint)(mm): $150.0
% Secondary: 0.0%
Shares Outstanding (mm): 31.0
Market Value at IPO Midpoint (mm): $464.3
Offering as % of Market Value: 32.3%
Bookrunners: Cowen | SVB Leerink | Credit Suisse | Wells Fargo
Major Holders: RTW Investments | Cormorant | Eli Lilly & Co. | ALETHEA Capital Management | EcoR1 Capital
Description: Avidity is pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOCs) designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases.
Note: Emerging Growth Company
Reference Link: S-1/A